Mevion, HATS to expand world’s smallest proton therapy system distribution in Asia

KUALA LUMPUR, Oct 20 -- Mevion Medical Systems has entered into a partnership agreement with Hermes Advanced Therapy Systems Corp (HATS) for the MEVION S250i Proton Therapy System® distribution in Taiwan and Southeast Asia, including Malaysia, Thailand and Singapore.

As a subsidiary of Hermes-Epitek Corp, a high-tech equipment and services provider, HATS will leverage the resources and support Mevion from project planning to customer support.

MEVION S250i Proton Therapy System with HYPERSCAN® Pencil Beam Scanning improves on proton therapy benefits by utilising an adaptive multi-leaf collimator to sharpen the beam and enables a more precise and conformal dose to the tumour than ever before.

It is the world’s smallest proton therapy system that eliminates obstacles of size, complexity and cost that exist with other proton therapy systems. 

According to a statement, the system’s advanced clinical capabilities in conjunction with its compact size has changed the landscape of proton therapy.

Proton therapy is a superior form of radiation therapy that can reduce the amount of unnecessary radiation exposure to surrounding healthy tissue and sensitive organs at risk. 

Adoption of proton therapy has been expanding rapidly because of the development of compact proton therapy systems.

Mevion was the first company to innovate this new approach to proton therapy and provides the most compact system available today.

-- BERNAMA